A detailed history of Bank Of America Corp transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Bank Of America Corp holds 130,061 shares of ARCT stock, worth $2.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130,061
Previous 198,557 34.5%
Holding current value
$2.38 Million
Previous $6.71 Million 52.78%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$24.35 - $44.39 $1.67 Million - $3.04 Million
-68,496 Reduced 34.5%
130,061 $3.17 Million
Q1 2024

May 15, 2024

BUY
$31.23 - $42.99 $4.95 Million - $6.81 Million
158,494 Added 395.61%
198,557 $6.71 Million
Q4 2023

Feb 14, 2024

SELL
$17.71 - $32.97 $3.47 Million - $6.46 Million
-196,051 Reduced 83.03%
40,063 $1.26 Million
Q2 2023

Aug 14, 2023

SELL
$23.94 - $32.36 $18.3 Million - $24.7 Million
-762,389 Reduced 76.35%
236,114 $6.77 Million
Q1 2023

May 12, 2023

BUY
$14.72 - $23.97 $4.6 Million - $7.49 Million
312,549 Added 45.56%
998,503 $23.9 Million
Q4 2022

Feb 10, 2023

BUY
$14.14 - $23.06 $8.17 Million - $13.3 Million
577,968 Added 535.22%
685,954 $11.6 Million
Q3 2022

Nov 14, 2022

BUY
$13.05 - $22.13 $1.17 Million - $1.98 Million
89,623 Added 488.06%
107,986 $1.6 Million
Q2 2022

Aug 12, 2022

SELL
$12.26 - $31.17 $473,346 - $1.2 Million
-38,609 Reduced 67.77%
18,363 $289,000
Q1 2022

May 16, 2022

SELL
$17.64 - $39.57 $1.25 Million - $2.8 Million
-70,653 Reduced 55.36%
56,972 $1.54 Million
Q4 2021

Feb 08, 2022

BUY
$34.2 - $47.56 $3.77 Million - $5.24 Million
110,195 Added 632.21%
127,625 $4.72 Million
Q3 2021

Nov 15, 2021

BUY
$27.88 - $58.25 $54,533 - $113,937
1,956 Added 12.64%
17,430 $833,000
Q2 2021

Sep 13, 2021

BUY
$25.79 - $42.11 $399,074 - $651,610
15,474 New
15,474 $524,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $487M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.